Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-070382
Filing Date
2025-05-13
Accepted
2025-05-13 16:15:37
Documents
72
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rani-20250331.htm   iXBRL 10-Q 1820516
2 EX-31.1 rani-ex31_1.htm EX-31.1 19260
3 EX-31.2 rani-ex31_2.htm EX-31.2 19294
4 EX-32.1 rani-ex32_1.htm EX-32.1 11664
  Complete submission text file 0000950170-25-070382.txt   8818650

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rani-20250331.xsd EX-101.SCH 1611169
75 EXTRACTED XBRL INSTANCE DOCUMENT rani-20250331_htm.xml XML 1475996
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40672 | Film No.: 25940331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)